Significance: No clear evidence of significant associations between choline and betaine intakes and cardiovascular disease mortality risk in Japanese men and women.
This systematic review and meta-analysis examined the effects of dietary cholesterol on cardiovascular disease risk in healthy adults. Forty studies (17 cohorts in 19 publications with 361,923 subjects and 19 trials in 21 publications with 632 subjects) published between 1979 and 2013 were eligible for review. Dietary cholesterol was not statistically significantly associated with any coronary artery disease (4 cohorts; no summary RR), ischemic stroke (4 cohorts; summary RR: 1.13; 95% CI: 0.99, 1.28), or hemorrhagic stroke (3 cohorts; summary RR: 1.09; 95% CI: 0.79, 1.50). Dietary cholesterol statistically significantly increased both Contact Us ILSI North America 1156 15th Street, NW Suite 200 Washington, DC 20005 Tel: 202.659.0074 Fax: 202.659.3859 ilsina@ilsi.org www.ilsina.org serum total cholesterol (17 trials; net change: 11.2 mg/dL; 95% CI: 6.4, 15.9) and LDL-cholesterol (14 trials; net change: 6.7 mg/dL; 95% CI: 1.7, 11.7 mg/dL). Increases in LDL-cholesterol were no longer statistically significant when intervention doses exceeded 900 mg/d. Dietary cholesterol also statistically significantly increased serum HDL-cholesterol (13 trials; net change: 3.2 mg/dL; 95% CI: 0.9, 9.7 mg/dL) and the LDL-to HDL-ratio (5 trials; net change: 0.2; 95% CI: 0.0, 0.3). Dietary cholesterol did not statistically significantly change serum triglycerides or VLDL concentrations.
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Metabolic and Physiologic Effects From Consuming a Hunter-Gatherer (Paleolithic)-Type Diet in Type 2 Diabetes U. Masharani, P. Sherchan, M. Schloetter, S. Stratford, A. Xiao, A. Sebastian, et al. European Journal of Clinical Nutrition, Vol. 69, No. 8; pp. 944-948, 2015 doi: 10.1038 /ejcn.2015 Link to full text: Click here Significance: Short-term consumption of a Paleolithic-type diet improved glucose control and lipid profiles in people with type 2 diabetes compared with a conventional diet containing moderate salt intake, low-fat dairy, whole grains and legumes.
This study investigated whether a diet similar to that consumed by our pre-agricultural hunter-gatherer ancestors ('Paleolithic' type diet) confers health benefits in 14 subjects with type 2 diabetes. The findings from the subjects on the Paleo diet (comprising lean meat, fruits, vegetables and nuts, and excluding added salt, and non-Paleolithic-type foods comprising cereal grains, dairy or legumes) were compared with 10 participants on a diet based on recommendations by the American Diabetes Association (ADA) containing moderate salt intake, low-fat dairy, whole grains and legumes. There were three ramp-up diets for 7 days, then 14 days of the test diet. Both groups had improvements in metabolic measures, but the Paleo diet group had greater benefits on glucose control and lipid profiles. Also, on the Paleo diet, the most insulin-resistant subjects had a significant improvement in insulin sensitivity (r=0.40, P=0.02), but no such effect was seen in the most insulin-resistant subjects on the ADA diet (r= 0.39, P=0.3). This 56-week randomized (2:1:1), double-blind, placebo-controlled, parallel-group trial investigated the efficacy and safety of liraglutide vs placebo for weight management in overweight or obese adults with type 2 diabetes, taking 0 to 3 oral hypoglycemic agents and glycated hemoglobin level 7.0% to 10.0%). Of 1361 participants assessed for eligibility, 846 were randomized. Subjects received oncedaily, subcutaneous liraglutide (3.0 mg) (n=423), liraglutide (1.8 mg) (n=211), or placebo (n=212) plus a 500 kcal/d dietary deficit, and increased physical activity (≥150 min/wk). Baseline weight was 105.7 kg with liraglutide (3.0 mg dose), 105.8 kg with liraglutide (1.8-mg dose), and 106.5 kg with placebo. Weight loss was 6.0% with 3.0 mg dose, 4.7% with 1.8-mg dose, and 2.0% with placebo. Weight loss of ≥5% occurred in 54.3% with 3.0 mg and 40.4% with 1.8 mg vs 21.4% with placebo. Weight loss ≥10% occurred in 25.2% with 3.0 mg and 15.9% with 1.8 mg vs 6.7% with placebo. More gastrointestinal disorders were reported with 3.0 mg vs 1.8 mg and placebo.
Efficacy of Liraglutide for Weight Loss Among Patients
Olive Oil Consumption and Risk of Type 2 Diabetes in US Women M. Guasch-Ferré, A. Hruby, J. Salas-Salvadó, M.A. Martínez-González, Q. Sun, W.C. Willett, et al. American Journal of Clinical Nutrition, Vol. 102, No. 2; pp. 479-486, 2015 doi: 10.3945/ajcn.115.112029 Link to full text: Click here Significance: Higher olive oil intake is associated with modestly lower risk of type 2 diabetes in women and that hypothetically substituting other types of fats and salad dressings with olive oil is inversely associated with diabetes.
The association between olive oil intake and incident type 2 diabetes (T2D) was evaluated in 59,930 women aged 37-65 y from the Nurses' Health Study (NHS) and 85,157 women aged 26-45 y from the NHS II who were free of diabetes, cardiovascular disease, and cancer at baseline. After 22 y of follow-up, 5738 and 3914 incident cases of T2D were documented in the NHS and NHS II, respectively. The pooled hazard ratio (HR) (95% CI) of T2D in those who consumed >1 tablespoon (>8 g) of total olive oil per day compared with those who never consumed olive oil was 0.90 (0.82, 0.99). The corresponding HRs (95% CIs) were 0.95 (0.87, 1.04) for salad dressing olive oil and 0.85 (0.74, 0.98) for olive oil added to food or bread. Substituting olive oil (8 g/d) for stick margarine, butter, or mayonnaise was associated with 5%, 8%, and 15% lower risk of T2D, respectively, in the pooled analysis of both cohorts. This controlled, double-blinded, randomized 2 × 5-wk crossover dietary intervention study examined the effects of moderate butter intake, moderate olive oil intake, and a habitual diet on blood lipids, high-sensitivity C-reactive protein (hsCRP), glucose, and insulin. During a 14-d run-in period subjects (n=47; mean total cholesterol: 5.22 ± 0.90 mmol/L) consumed their habitual diets and substituted a part of their habitual diets with 4.5% of energy from butter or refined olive oil. Butter intake increased total cholesterol and LDL-cholesterol more than did olive oil intake (P < 0.05) and the run-in period (P < 0.005 and P < 0.05, This randomized, placebo-controlled, double-blind crossover trial examined whether increased dietary nitrate intake by using beetroot juice for 1 wk lowers blood pressure in 27 treated hypertensive men and women. The effect of 1-wk intake of nitrate-rich beetroot juice was compared with 1-wk intake of nitrate-depleted beetroot juice (placebo). Relative to the placebo, 1-wk intake of nitrate-rich beetroot juice resulted in a 3-fold increase in plasma nitrite and nitrate, a 7-fold increase in salivary nitrite, an 8-fold higher salivary nitrate, and a 4-fold increase in both urinary nitrite and nitrate (P < 0.001). However, no differences in blood pressure were observed with 1-wk intake of nitrate-rich beetroot juice in comparison with the placebo.
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Consensus Communication on Early Peanut Introduction and the Prevention of Peanut Allergy in High-Risk Infants D.M. Fleischer, S. Sicherer, M. Greenhawt, D. Campbell, E. Chan, A. Muraro, et al. Journal of Allergy and Clinical Immunology, Vol. 136, No. 2; pp. 258-261, 2015 doi: 10.1016 /j.jaci.2015 Link to full text: Click here Significance: This paper highlights emerging evidence for existing allergy prevention guidelines regarding potential benefits of supporting early rather than delayed peanut introduction during the period of complementary food introduction in infants.
Based on data generated in the Learning Early About Peanut Allergy (LEAP) trial, the following interim guidance is suggested to assist the clinical decision making of health care providers. Health care providers should recommend introducing peanut-containing products into the diets of "high-risk" infants between 4 and 11 months of age in countries where peanut allergy is prevalent because delaying the introduction of peanut can be associated with an increased risk of peanut allergy. Infants with early-onset atopic disease, such as severe eczema, or egg allergy in the first 4 to 6 months of life, might benefit from evaluation by an allergist or physician trained in management of allergic diseases in this age group to diagnose any food allergy and assist in implementing these suggestions regarding the appropriateness of early peanut introduction. Without intervention by health care providers, there is the potential that such high-risk infants will remain at risk for delayed introduction of solids and allergenic foods into their diet because of the widespread belief that such foods can exacerbate eczema.
Sugar-Sweetened beverages
Consumption of Sucrose-Sweetened Soft Drinks Increases Plasma Levels of Uric Acid in Overweight and Obese Subjects: A 6-Month Randomised Controlled Trial J.M. Bruun, M. Maersk, A. Belza, A. Astrup, B. Richelsen European Journal of Clinical Nutrition, Vol. 69, No. 8; pp. 949-953, 2015 doi:10.1038 /ejcn.2015 Link to full text: Click here Significance: Daily intake of 1 L sucrose-sweetened soft drinks for 6 months was found to increase circulating uric acid levels compared with isocaloric milk, diet cola and water.
This study investigated the long-term effects of consuming sucrose-sweetened soft drinks (SSSDs) on circulating levels of uric acid (UA) in 47 non-diabetic overweight and obese subjects who were randomized to consume 1 L daily of either SSSD (regular cola), isocaloric semi-skimmed milk, diet cola or water for 6 months. Circulating UA levels increased ~15% (P=0.02) after the 6-month intervention in the SSSD group with no change in the other groups. In the SSSD group, circulating UA levels increased significantly after the intervention in both absolute (P=0.005) and relative values (P=0.004). The change in UA after the intervention correlated with changes in liver fat (P=0.005), triglycerides (P=0.02) and insulin (P=0.002).
